Previous years' contract solicitations
PHS 2024 included 11 contract topics released by NCI:
- 455 - Point-of-Care Detection of Prostate-Specific Antigen
- 456 - Rapid and Affordable Point-of-Care HPV Diagnostics for Cervical Cancer Control
- 457 - Technologies for Detecting Tumor-Derived Cell Clusters
- 458 - Microbiome-Based Tests for Cancer Research, Diagnosis, Prognosis and/or Patient Management
- 459 - Automated Software for Point-of-Care Testing to Identify Cancer-Associated Malnutrition
- 460 - Evaluation Datasets as Medical Device Development Tools for Testing Cancer Technologies
- 461 - Ultra-Fast Dose Rate (FLASH) Radiation Detectors and Safety Systems for Cancer Treatment
- 462 - Organ-on-Chip for Preclinical and Translational Radiobiological Studies
- 463 - Translation of Novel Cancer-specific Imaging Agents and Techniques to Mediate Successful Image-guided Cancer Interventions
- 464 - Cloud-Based Multimodal Data Analysis Software for the Cancer Research Data Commons
- 465 - Prevention and Treatment Clinical Trials Tools for Recruitment and Retention of Diverse Populations
PHS 2023 included 9 contract topics released by NCI:
- 446 - Development of Senotherapeutic Agents for Cancer Treatment
- 447 - Non-invasive Device Technology Research & Development for Chemotherapy-induced Peripheral Neuropathy Management
- 448 - Wearable Devices for Dosimetry of Radiopharmaceutical Therapy
- 449 - Wearable Technologies to Facilitate Remote Monitoring of Cancer Patients Following Treatment
- 450 - Technology Platforms for Circulating Tumor-Macrophage Hybrid Cells
- 451 - Rapid and Affordable Point-of-Care HPV Diagnostics for Cervical Cancer Control
- 452 - Translation of Novel Cancer-Specific Imaging Agents and Techniques to Mediate Successful Image-Guided Cancer Interventions
- 453 - Digital Tools to Integrate Cancer Prevention Within Primary Care
- 454 - Software to Evaluate Artificial Intelligence/Machine Learning Medical Devices in Oncology Settings
PHS 2022 included 16 contract topics released by NCI:
- 430 - Development of Senotherapeutic Agents for Cancer Treatment
- 431 - Cancer Treatment Technologies for Low-resource Settings
- 432 - Synthetic Biology Gene Circuits for Cancer Therapy
- 433 - Developing Unbiased Medical Technologies to Reduce Disparities in Cancer Outcomes
- 434 - Ultra-fast Dose Rate (FLASH) Radiation Detectors and Safety Systems
- 435 - Devices to Treat Secondary Lymphedema Following Cancer Treatment
- 436 - New Technologies to Analyze Extra-chromosomal DNA in Cancer
- 437 - 3D Spatial Omics for Molecular and Cellular Tumor Atlas Construction
- 438 - Understanding Cancer Tumor Genomic Results: Technology Applications for Community Providers
- 439 - Advanced Sample Processing Platforms for Downstream Single-cell Multi-omic Analysis
- 440 - Cancer Prevention and Diagnosis Technologies for Low-resource Settings
- 441 - At-home Screening for Hepatitis C Virus
- 442 - Quantitative Biomarkers as Medical Device Development Tools for Cancer
- 443 - Development of Computer-aided Diagnosis Tools for Upper and Lower Gastrointestinal Tract Cancer Prevention
- 444 - Evaluation Datasets as Medical Device Development Tools for Testing Cancer Technologies
- 445 - Advanced Manufacturing to Speed Availability of Emerging Autologous Cell-based Therapies
PHS 2021 included 17 contract topics released by NCI:
- 413 - Next Generation 3D Tissue Culture Systems with Tertiary Lymphoid Organs
- 414 - Synthetic Biology Gene Circuits for Cancer Therapy
- 415 - Applicator-Compatible Electronic Brachytherapy Sources for Cancer Radiotherapy
- 416 - Self-Sampling Devices for HPV-Testing-Based Cervical Cancer Screening
- 417 - Quantitative Imaging Software Tools for Cancer Diagnosis and Treatment Planning
- 418 - 3D Spatial Omics for Molecular and Cellular Tumor Atlas Construction
- 419 - Understanding Cancer Tumor Genomic Results: Technology Applications for Providers
- 420 - Single-Cell “Unbiased Discovery” Proteomic Technologies
- 421 - Quantitative Biomimetic Phantoms for Cancer Imaging and Radiation Dosimetry
- 422 - Spatial Sequencing Technologies with Single Cell Resolution for Cancer Research and Precision Medicine
- 423 - Software to Address Social Determinants of Health in Oncology Practices
- 424 - Digital Tools to Improve Health Outcomes in Pediatric Cancer Survivors
- 425 - Information Technology Tools for Automated Analysis of Physical Activity, Performance, and Behavior from Images for Improved Cancer Health
- 426 - Tools and Technologies for Visualizing Multi-Scale Data
- 427 - De-Identification Software Tools and Pipelines for Cancer Imaging Research
- 428 - Cloud-Based Multi-Omic and Imaging Software for the Cancer Research Data Commons
- 429 - Advanced Manufacturing to Speed Availability of Emerging Autologous Cell-Based Therapies
PHS 2020 included 16 contract topics released by NCI:
- 397 - Manufacturing Innovation for the Production of Cell-Based Cancer Immunotherapies
- 398 - Development of Senolytic Agents for Cancer Treatment
- 399 - Combinatory Treatment Utilizing Radiation to Locally Activate Systemically Delivered Therapeutics
- 400 - Sensing Tools to Measure Biological Response to Radiotherapy
- 401 - Quantitative Biomimetic Phantoms for Cancer Imaging
- 402 - Artificial Intelligence-Aided Imaging for Cancer Prevention, Diagnosis, and Monitoring
- 403 - Spatial Sequencing Technologies with Single Cell Resolution for Cancer Research
- 404 - Subcellular Microscopy and -Omics in Cancer Cell Biology
- 405 - Intra-Tumor Sensing Technologies for Tumor Pharmacotyping
- 406 - Software for Patient Navigation Through the Cancer Care Continuum
- 407 - Cloud-Based Software for the Cancer Research Data Commons
- 408 - Tools and Technologies for Visualizing Multi-Scale Data
- 409 - Software for Automated Analysis of Images for Improved Cancer Health
- 410 - Cancer Clinical Trials Recruitment and Retention Tools for Participant Engagement
- 411 - De-Identification Software Tools for Cancer Imaging Research
- 412 - Software Enabling Data Integration from Wearable Sensors for Cancer Patients
PHS 2019 included 15 contract topics released by NCI:
- 382 - Integrated Subcellular Microscopy and ‘Omics in Cancer Cell Biology
- 383 - Smart, Multi-Core Biopsy Needle
- 384 - Digital Healthcare Platform to Reduce Financial Hardship for Cancer Patients
- 385 - Leveraging Connected Health Technologies to Address and Improve Health Outcomes of Long-Term Cancer Survivors
- 386 - Novel Approaches for Local Delivery of Chemopreventive Agents
- 387 - Multiplexed Preclinical Tools for Longitudinal Characterization of Immunological Status in Tumor and its Microenvironment
- 388 - In vitro Diagnostic for the Liver Flukes Opisthorchis viverrini and Clonorchis sinensis
- 389 - Development of Artificial Intelligence (AI) Tools to Understand and Duplicate Experts' Radiation Therapy Planning for Prostate Cancer
- 390 - Clonogenic High-Throughput Assay for Screening Anti-Cancer Agents and Radiation Modulators
- 391 - Drugs or Devices to Exploit the Immune Response Generated by Radiation Therapy
- 392 - Clinical Trials of Systemic Targeted Radionuclide Therapies
- 393 - Sensing Tools to Measure Biological Response to Radiotherapy
- 394 - Combinatory Treatment Modalities Utilizing Radiation to Locally Activate or Release Systemically Delivered Therapeutics
- 395 - Targeted Therapy for Cancer- and Cancer Therapy-Related Cachexia
- 396 - Imaging for Cancer Immunotherapies
PHS 2018 included 12 contract topics released by NCI:
- 370 - Targeted Therapy for Cancer- and Cancer Therapy-Related Cachexia
- 371 - Drugs to Exploit the Immune Response Generated by Radiation Therapy
- 372 - Development and Validation of Non-Mouse Reagents to Enable Preclinical Development of Novel Therapeutics
- 373 - Tools and Technologies for Monitoring RNA Modifications
- 374 - Novel Approaches for Local Delivery of Chemopreventive Agents
- 375 - Diagnostic Imaging for Cancer Immunotherapies
- 376 - Imaging-Based Tools for Longitudinal and Multi-Dimensional Mapping of the Tumor and its Microenvironment
- 377 - Bridging the Guideline Implementation Gap: Clinical Decision-Support to Improve Cancer Symptom Management
- 378 - Mobile Application for Surveillance of Post-Radiation Therapy Health-Related Quality of Life
- 379 - Software Enabling Data Integration from Wearable Sensors to Generate Novel Analytics for Cancer Patients
- 380 - Computer Aided Decision Support for Radiation Oncology
- 381 - Development of Artificial Intelligence (AI) Tools to Understand and Duplicate Experts’ Radiation Therapy Planning for Prostate Cancer